What sector does ILYANG PHARMACEUTICAL CO.,LTD belong to?

ILYANG PHARMACEUTICAL CO.,LTD operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.

What is the current share price of 007570?

As of the latest available quote, 007570 traded at ₩8,070.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 007570?

ILYANG PHARMACEUTICAL CO.,LTD has a price-to-earnings (P/E) ratio of about 21.52. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 007570?

The market capitalisation of ILYANG PHARMACEUTICAL CO.,LTD is approximately ₩153.50B.

Is ILYANG PHARMACEUTICAL CO.,LTD profitable?

For its latest reported financial year, ILYANG PHARMACEUTICAL CO.,LTD recorded a net profit margin of about 2.62%.

Does 007570 pay a dividend?

ILYANG PHARMACEUTICAL CO.,LTD currently has a dividend yield of about 1.19%.

What is the return on equity (ROE) of 007570?

ILYANG PHARMACEUTICAL CO.,LTD has a return on equity (ROE) of about 2.91%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 007570?

Over the past 52 weeks, 007570 has traded between a low of ₩7,290.00 and a high of ₩16,240.00.

ILYANG PHARMACEUTICAL CO.,LTD

007570 KRX Pharmaceuticals Pharmaceuticals

KOSPI

₩8,070.00

-2.42%

Delayed · cached 15 min

Fair value analysis

007570

ILYANG PHARMACEUTICAL CO.,LTD

₩8,070.00

Close used for this calculation

₩6,538.33Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

34/100

Profitability12/25

Returns5/25

Balance Sheet10/25

Efficiency7/25

Growth12/25

Weak

Quality radar

Consensus fair value

₩6,538.33

Above FV

▼ -19.0% against the close used

Model range ₩535.32 – ₩10,565.22

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩535.32Fair value₩6,538.33Bull₩10,565.22

FairClose

52-week traded range

52W low ₩7,320.0052W high ₩13,630.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

ILYANG PHARMACEUTICAL CO.,LTD closed at ₩8,070.00, 23.4% above the consensus fair value of ₩6,538.33 drawn from 10 valuation models.

Financial DNA score 34/100 — Weak. P/E of 21.5x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩6,230.85

-22.8%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₩10,565.22

+30.9%

√(22.5 × EPS × BVPS)

EPS=375, BVPS=13229.51

Graham Formula

₩4,250.00

-47.3%

EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate

g=0%, FD=3.3%

P/E Fair Value

₩7,500.00

-7.1%

EPS × 20x (sector P/E)

EPS=375, Sector P/E=20x

Peter Lynch (PEG)

₩5,812.50

-28.0%

EPS × Growth% (PEG = 1 is fair)

EPS=375, g=15.5%

EV/EBITDA

₩535.32

-93.4%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=13.31B

Dividend Discount (DDM)

₩1,224.42

-84.8%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=96.03, r=10%, g=2%

Book Value (P/B)

₩3,849.79

-52.3%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=13229.51, ROE=2.9%, g=3%, r=10%

Reverse DCF

₩8,070.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 8.1% | Historical: -15.5%

Margin of Safety

₩5,352.39

-33.7%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=7136.52, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer